Closed NkRMnZr closed 1 year ago
Tracking updates:
08-05, 4 seqs from USA: EPI_ISL_18057063, EPI_ISL_18069764, EPI_ISL_18069768, EPI_ISL_18069925
08-11, 4 seqs from Sweden, mini-saltation with S:A484S and S:T883I
08-11, 4 seqs from Sweden, mini-saltation with S:A484S
and S:T883I
: EPI_ISL_18089985, EPI_ISL_18089987, EPI_ISL_18089990, EPI_ISL_18089995
UShER for seqs submitted since Aug 1:
Now it already forms 3 different mini-saltation branches:
Although this has no growth advantage: https://cov-spectrum.org/explore/World/AllSamples/Past3M/variants?aaMutations=Orf1b%3AD54N&nucMutations1=T23485A%2CC25521T&analysisMode=CompareToBaseline&
I think the remarkable spike diversity shown in its tree strongly points to an undersampled circualtion somewhere. EPI_ISL_17395881 collected in Japan back in March from a traveller coming from Somalia and EPI_ISL_17537913 collected earlier in April from a traveller from Kenya could throw some lights on which is that undersampled area.
So i think it should be proposed in the main page specifying these two seqeucnes and the spike diversity shown: (three big branches each with S:259S or S:P809T or S:E471Q as highlighted above by @NkRMnZr )
Ping @corneliusroemer lineage from an undersampled area with a lot of S diversity.
NkRMnZr asked what S:N6411K does. One thing is that it adds a proteolytic cleavage site that is a target of the HAT (Human Airway Trypsin-like) protease, which could cleave the spike protein at this site. This would change the protein shape in the airway (nasal passage to lungs) without changing its shape elsewhere in the body (e.g. change transmissibility without affecting infectability of tissues outside of the airway).
NkRMnZr asked what S:N6411K does. One thing is that it adds a proteolytic cleavage site that is a target of the HAT (Human Airway Trypsin-like) protease, which could cleave the spike protein at this site. This would change the protein shape in the airway (nasal passage to lungs) without changing its shape elsewhere in the body (e.g. change transmissibility without affecting infectability of tissues outside of the airway).
References?
NkRMnZr asked what S:N6411K does. One thing is that it adds a proteolytic cleavage site that is a target of the HAT (Human Airway Trypsin-like) protease, which could cleave the spike protein at this site. This would change the protein shape in the airway (nasal passage to lungs) without changing its shape elsewhere in the body (e.g. change transmissibility without affecting infectability of tissues outside of the airway).
Thanks! Any ref to the study?
NkRMnZr asked what S:N6411K does. One thing is that it adds a proteolytic cleavage site that is a target of the HAT (Human Airway Trypsin-like) protease, which could cleave the spike protein at this site. This would change the protein shape in the airway (nasal passage to lungs) without changing its shape elsewhere in the body (e.g. change transmissibility without affecting infectability of tissues outside of the airway).
Thanks! Any ref to the study?
@thomaspeacock pointed to this one: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167920/
Thanks, Fede. However, I don't think that study says anything about S:N641K creating a HAT cleavage site. Instead, it claims—convincingly, I think—that a cleavage site already exists at S:Y636.
This isn't to say that N641K couldn't create a HAT cleavage site (something I'm not familiar with at all), only that I don't see any support for that idea in this paper.
Transferred to github.com/cov-lineages/pango-designation#2180
Thx @ryhisner for clarifying!
Defining Mutations:
FL.2
>C25521T
>T23485A(S:N641K), A29683T
Query:T23485A, C25521T
Earliest seq: 2023-03-15 (EPI_ISL_17363241
, England, UK) Latest seq: 2023-07-13 (EPI_ISL_18055042
, California, USA) Sampled Countries: USA (19, California/13, Arizona/4, New York/2), Sweden (17), Canada (9, Ontario), UK (6, England/5, Scotland/1), France (2), Austria (1), China (1, Shanghai), Germany (1), India (1), Ireland (1), Israel (1), Italy (1), Japan (1), Spain (1)Genomes:
`EPI_ISL_17363241, EPI_ISL_17395881, EPI_ISL_17400810, EPI_ISL_17448553, EPI_ISL_17488308, EPI_ISL_17488334, EPI_ISL_17511907, EPI_ISL_17514054, EPI_ISL_17537803, EPI_ISL_17537913, EPI_ISL_17549297, EPI_ISL_17553672, EPI_ISL_17555869, EPI_ISL_17558172, EPI_ISL_17590487, EPI_ISL_17630281, EPI_ISL_17630455, EPI_ISL_17630478, EPI_ISL_17664440, EPI_ISL_17668930, EPI_ISL_17668978, EPI_ISL_17668999, EPI_ISL_17690272, EPI_ISL_17713615, EPI_ISL_17721736, EPI_ISL_17722643-17722644, EPI_ISL_17722718, EPI_ISL_17731144, EPI_ISL_17731521, EPI_ISL_17732731, EPI_ISL_17732763, EPI_ISL_17732771, EPI_ISL_17732773, EPI_ISL_17732812, EPI_ISL_17732815, EPI_ISL_17732819, EPI_ISL_17764343, EPI_ISL_17764728, EPI_ISL_17767911, EPI_ISL_17768311, EPI_ISL_17769714, EPI_ISL_17781527, EPI_ISL_17791659, EPI_ISL_17797041, EPI_ISL_17809292, EPI_ISL_17809729, EPI_ISL_17838302, EPI_ISL_17838841, EPI_ISL_17854148, EPI_ISL_17855011, EPI_ISL_17950471, EPI_ISL_17950512, EPI_ISL_17951643, EPI_ISL_17981065, EPI_ISL_18005336, EPI_ISL_18010050, EPI_ISL_18045881, EPI_ISL_18046161, EPI_ISL_18046249, EPI_ISL_18046277, EPI_ISL_18055042`UShER: https://nextstrain.org/fetch/genome.ucsc.edu/trash/ct/subtreeAuspice1_genome_36e64_922b50.json?f_userOrOld=uploaded%20sample
Trivia:
S:N641K
does, but it does seems to have a lot of positive charge. Only sampled 170 times during the whole pandemic, about 1/3 is from this branch.S:259S, E554A
andK356N
, but there are also mutations likeS:P809T
,E471Q
from other branches.